Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1025 | 9778 | 44.2 | 92% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
230 | 44735 | TISSUE ANTIGENS//ANKYLOSING SPONDYLITIS//IMMUNOGENETICS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1523 | 2527 | KIR//LY49//KILLER CELL IMMUNOGLOBULIN LIKE RECEPTORS |
4504 | 1700 | NKG2D//NKG2D LIGANDS//MICB |
5718 | 1518 | ECCELLENZA RIC BIOMED//NKG2C//NK CELL MATURATION |
5838 | 1499 | HLA G//SOLUBLE HLA G//SERV RECH HEMATOIMMUNOL |
10080 | 1030 | INTERLEUKIN 15//IL 15//IL 15R ALPHA |
14573 | 695 | LAIR 1//CD300A//FCRL |
16122 | 605 | TREM 1//NASU HAKOLA DISEASE//TREM2 |
26650 | 204 | CD69//CD69 ANTIGEN//A20 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HLA G | Author keyword | 964 | 86% | 5% | 487 |
2 | KIR | Author keyword | 319 | 72% | 3% | 249 |
3 | NKG2D | Author keyword | 258 | 67% | 2% | 233 |
4 | NK CELLS | Author keyword | 211 | 28% | 7% | 656 |
5 | NATURAL KILLER CELLS | Author keyword | 158 | 24% | 6% | 572 |
6 | INTERLEUKIN 15 | Author keyword | 155 | 56% | 2% | 187 |
7 | HLA E | Author keyword | 155 | 76% | 1% | 107 |
8 | SOLUBLE HLA G | Author keyword | 153 | 98% | 0% | 41 |
9 | IL 15 | Author keyword | 130 | 47% | 2% | 203 |
10 | LY49 | Author keyword | 128 | 86% | 1% | 64 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HLA G | 964 | 86% | 5% | 487 | Search HLA+G | Search HLA+G |
2 | KIR | 319 | 72% | 3% | 249 | Search KIR | Search KIR |
3 | NKG2D | 258 | 67% | 2% | 233 | Search NKG2D | Search NKG2D |
4 | NK CELLS | 211 | 28% | 7% | 656 | Search NK+CELLS | Search NK+CELLS |
5 | NATURAL KILLER CELLS | 158 | 24% | 6% | 572 | Search NATURAL+KILLER+CELLS | Search NATURAL+KILLER+CELLS |
6 | INTERLEUKIN 15 | 155 | 56% | 2% | 187 | Search INTERLEUKIN+15 | Search INTERLEUKIN+15 |
7 | HLA E | 155 | 76% | 1% | 107 | Search HLA+E | Search HLA+E |
8 | SOLUBLE HLA G | 153 | 98% | 0% | 41 | Search SOLUBLE+HLA+G | Search SOLUBLE+HLA+G |
9 | IL 15 | 130 | 47% | 2% | 203 | Search IL+15 | Search IL+15 |
10 | LY49 | 128 | 86% | 1% | 64 | Search LY49 | Search LY49 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INHIBITORY RECEPTORS | 1072 | 61% | 12% | 1129 |
2 | NK CELLS | 681 | 32% | 18% | 1741 |
3 | G EXPRESSION | 626 | 89% | 3% | 281 |
4 | NATURAL KILLER CELLS | 604 | 20% | 27% | 2682 |
5 | G MESSENGER RNA | 537 | 92% | 2% | 211 |
6 | LEUKOCYTE ANTIGEN G | 430 | 85% | 2% | 230 |
7 | IMMUNOGLOBULIN LIKE RECEPTORS | 405 | 75% | 3% | 294 |
8 | G MOLECULES | 284 | 92% | 1% | 113 |
9 | G GENE | 260 | 86% | 1% | 133 |
10 | IMMUNOGLOBULIN LIKE RECEPTOR | 254 | 81% | 2% | 153 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Innate or Adaptive Immunity? The Example of Natural Killer Cells | 2011 | 486 | 76 | 84% |
NK cell recognition | 2005 | 1346 | 340 | 75% |
Functions of natural killer cells | 2008 | 729 | 107 | 64% |
Regulation of Ligands for the NKG2D Activating Receptor | 2013 | 110 | 138 | 70% |
Human natural killer cells | 2008 | 469 | 111 | 74% |
Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective | 2015 | 8 | 126 | 58% |
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition | 2013 | 113 | 198 | 54% |
Effect of NKG2D ligand expression on host immune responses | 2010 | 190 | 140 | 81% |
Roles of the NKG2D immunoreceptor and its ligands | 2003 | 686 | 74 | 78% |
NKG2D signaling in cancer immunosurveillance | 2015 | 4 | 149 | 76% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SERV RECH HEMATOIMMUNOL | 110 | 81% | 0.7% | 67 |
2 | ECCELLENZA RIC BIOMED | 96 | 61% | 1.0% | 101 |
3 | RECEPTOR CELL BIOL SECT | 42 | 75% | 0.3% | 30 |
4 | SERV RECH HEMATO IMMUNOL | 41 | 90% | 0.2% | 18 |
5 | HUMAN TISSUE BANK | 30 | 64% | 0.3% | 29 |
6 | CEA DSV DRM | 23 | 86% | 0.1% | 12 |
7 | SEZ ISTOL | 22 | 47% | 0.4% | 35 |
8 | DIPARTIMENTO MED SPERIMENTALE | 21 | 11% | 1.8% | 176 |
9 | CIRRI | 20 | 100% | 0.1% | 9 |
10 | NO IRELAND REG HISTOCOMPATIBIL IMMUNOGENET | 16 | 45% | 0.3% | 27 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000016286 | INTERLEUKIN 2//GRANZYME B//PERFORIN |
2 | 0.0000013933 | CD1D//GAMMA DELTA T CELLS//ALPHA GALACTOSYLCERAMIDE |
3 | 0.0000011526 | TISSUE ANTIGENS//IMMUNOGENETICS//HUMAN IMMUNOLOGY |
4 | 0.0000009977 | FOXP3//CTLA 4//REGULATORY T CELLS |
5 | 0.0000009559 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY |
6 | 0.0000009449 | CLEANING VALIDATION//SWAB ANALYSIS//CLEANING VERIFICATION |
7 | 0.0000008565 | ORAL TOLERANCE//DC SIGN//DENDRITIC CELLS |
8 | 0.0000008327 | ENDOMETRIUM//AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY//DECIDUA |
9 | 0.0000008278 | HLA B8 DR3//INTERDISCIPLINARY STUDIES SECT//AH 81 |
10 | 0.0000007119 | ANKYLOSING SPONDYLITIS//HLA B27//SPONDYLOARTHRITIS |